Drugs / ISOXAFLUTOLE
ISOXAFLUTOLE
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01985321 | Nov 2013 → Mar 2014 | herpes labialis | Topical Remedy | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01837472 | Apr 2012 → Jan 2013 | irritable bowel syndrome | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01753154 | Jul 2011 → Mar 2013 | chronic renal failure syndrome | Fresenius Medical Care Deutschland GmbH | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT03192306 Comparator | Jul → Dec 2017 | herpes labialis | Topical Remedy | Completed | No outcome recorded |
| Phase 3 | NCT03994471 Comparator | Dec 2022 → Dec 2026 expected | end stage renal failure | Iperboreal Pharma Srl | Recruiting | No outcome recorded |
| Phase 4 | NCT01315314 Comparator | Oct 2005 → Apr 2008 | chronic renal failure syndrome | Kyungpook National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01632046 Comparator | Mar 2004 → Mar 2007 | chronic renal failure syndrome | Heidelberg University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ISOXAFLUTOLE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1887147 ↗ |
| Known as | 264-EUP-99 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1887147 ↗ |
| Known as | balance | “Patients in the probiotic group received the probiotic compound Balance® (Protexin Co., Somerset, UK) or similar placebo, twice daily after meal for 14 consecutive days.” NCT01837472 ↗4“If patient is randomised to the Balance arm, he will be dialysed with lactate based PD fluid (Balance) for 10 months.” NCT01632046 ↗ “Balance, Bicavera, Bicanova or Equibalance have 1.25%, 2.3%, 4.5% glucose” NCT03994471 ↗ |
| Known as | Merlin | “The purpose of this study is to determine if Merlin, a mixture of ethanol and glycolic acid, is safe and effective in the treatment of cold sores.” NCT03192306 ↗1“Merlin (Ethanol and Glycolic Acid Mixture)” NCT01985321 ↗ |
| Known as | RPA-201772 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1887147 ↗ |
| Modality | Other / unclassified | “We hypothesize that the multistrain probiotic Balance containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains, and Streptococcus thermophiles...” NCT01837472 ↗ |
| Route | Topical | “put the Merlin or placebo solution on their cold sore” NCT01985321 ↗ |